Multi-Center Study To Examine The Use Of Flex HD® And Strattice In The Repair Of Large Abdominal Wall Hernias
A Randomized, Prospective, Double-blind, Multi-Center Study To Examine And Compare The Outcomes Associated With The Use Of Flex HD®, A Human Acellular Dermal Matrix, And Strattice™, A Porcine Acellular Dermal Matrix Allograft, When Used As A Reinforcing Material In The Repair Of Large Abdominal Wall Hernias By A Component Separation Technique
Sponsor: Meridian Healthcare System
Listed as NCT01987700, this PHASE4 trial focuses on Hernia of Abdominal Wall and remains completed. Sponsored by Meridian Healthcare System, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2018 — Jan 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Unknown Status PHASE4
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Feb 2017 — Oct 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Meridian Healthcare System
- Musculoskeletal Transplant Foundation
- Pines Surgical
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .